Lantheus Holdings (LNTH) had its Relative Strength (RS) Rating upgraded from 80 to 83 Tuesday.
↑ XThis exclusive rating from Investor's Business Daily tracks share price movement with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the best-performing stocks tend to have an 80 or higher RS Rating in the early stages of their moves.
Risk Management In The Stock Market: How Much Money To Invest Now
While Lantheus Holdings is not near an ideal buy zone right now, see if it goes on to form and break out of a proper consolidation.
Lantheus Holdings showed 16% EPS growth in the latest quarterly report. Sales gains came in at 18%.
The company holds the No. 8 rank among its peers in the Medical-Products industry group. Globus Medical (GMED), Pro-Dex (PDEX) and Insulet (PODD) are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。